Consolidated Investment Group’s AbbVie ABBV Stock Holding History

Consolidated Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.71M	Hold	30,650	–	–	0.67%	29
2026 Q1	$6.67M	Buy	30,650 +4,815	+19%	+$1.07M	0.72%	27
2025 Q4	$5.9M	Hold	25,835	–	–	0.71%	30
2025 Q3	$5.98M	Hold	25,835	–	–	0.73%	30
2025 Q2	$4.8M	Hold	25,835	–	–	0.64%	34
2025 Q1	$5.41M	Sell	25,835 -1,065	-4%	-$207K	0.83%	29
2024 Q4	$4.78M	Hold	26,900	–	–	0.67%	36
2024 Q3	$5.31M	Hold	26,900	–	–	0.79%	35
2024 Q2	$4.61M	Hold	26,900	–	–	0.72%	37
2024 Q1	$4.9M	Buy	26,900 +12,300	+84%	+$2.12M	0.79%	34
2023 Q4	$2.26M	Hold	14,600	–	–	0.4%	50
2023 Q3	$2.18M	Buy	14,600 +3,600	+33%	+$528K	0.42%	53
2023 Q2	$1.48M	Hold	11,000	–	–	0.27%	56
2023 Q1	$1.75M	Buy	+11,000	New	+$1.68M	0.34%	55

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Consolidated Investment Group's ABBV Position: Q2 2026 in Review

Consolidated Investment Group held its AbbVie (ABBV) position steady in Q2 2026 at 30,650 shares worth $7.71M. The position accounts for 0.67% of the portfolio, ranked #29.

Consolidated Investment Group first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Consolidated Investment Group held 30,650 shares of AbbVie worth $7.71M as of Q2 2026.
Consolidated Investment Group left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.67% of Consolidated Investment Group's portfolio in Q2 2026, its #29 holding.
Consolidated Investment Group first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Consolidated Investment Group's 13F filing for Q2 2026, filed 22 Jul 2026.